WPD Pharmaceuticals (TSE:WBIO) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
WPD Pharmaceuticals has successfully negotiated the settlement of its debt with creditors, who have agreed to accept common shares in exchange for debt forgiveness. Additionally, the company’s former subsidiary, WPD Poland, has restructured into WPD Pharmaceuticals S.A., with the parent company retaining approximately 6% ownership post-restructuring. This move comes alongside an investment in WPD S.A. by ACRX Investments Limited, which has resulted in a slight dilution of WPD’s ownership stake to about 5%.
For further insights into TSE:WBIO stock, check out TipRanks’ Stock Analysis page.